Status:

COMPLETED

Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases

Lead Sponsor:

EpicentRx, Inc.

Conditions:

Brain Metastases

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

In this dose-escalation study, the safety and tolerability of escalating dose levels of RRx-001 administered intravenously twice a week in subjects with brain metastases receiving whole brain radiatio...

Detailed Description

The purpose of this research study is to test the safety and activity of whole brain radiation therapy with RRx-001, an experimental radiation sensitizer, in participants with brain metastases. As a r...

Eligibility Criteria

Inclusion

  • Written informed consent
  • Age ≥18 years
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • One or more brain metastases
  • Prior radiation therapy to the brain is allowed with the exception of whole brain irradiation
  • Subjects must be neurologically stable for at least 14 days prior to first dose of study drug;
  • Male and female subjects who are not surgically sterile or post-menopausal must agree to use reliable methods of birth control for the duration of the study and for 90 days after the last dose of study drug administration; male partners of female subjects should use condoms for the duration of the study, and for 90 days after the last dose of study drug administration

Exclusion

  • Pregnant or lactating females
  • Any evidence of severe or uncontrolled diseases
  • Inadequate bone marrow reserve
  • Previous whole brain radiotherapy
  • Prior RRx-001 therapy
  • Insufficient recovery from all side effects of previous anticancer therapies
  • Evidence of blood clotting or bleeding abnormalities

Key Trial Info

Start Date :

February 6 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 12 2020

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT02215512

Start Date

February 6 2015

End Date

November 12 2020

Last Update

November 3 2021

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Providence Saint John's Health Center

Santa Monica, California, United States, 90404

2

University of Michigan

Ann Arbor, Michigan, United States, 48109

3

Allegiance Health

Jackson, Michigan, United States, 49201

4

Washington University School of Medicine

St Louis, Missouri, United States, 63110